State AL
Clinical Trials in Alabama
Alabama is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Alabama and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 191 actively recruiting studies with Alabama sites out of 191 registered in total. The busiest research areas in Alabama are Multiple Myeloma, Obesity, Breast Cancer. Leading sponsors running trials in the state include University of Alabama at Birmingham, National Cancer Institute (NCI), AstraZeneca. By stage, Alabama trials break down as Phase 1 (28), Phase 2 (51), Phase 3 (58), Phase 4 (3).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Alabama
Frequently Asked Questions — Clinical Trials in Alabama
How many clinical trials are currently recruiting in Alabama?
ClinicalMetric currently tracks 191 actively recruiting clinical trials with at least one location in Alabama. The total number of registered studies—including active but not currently enrolling trials—is 191. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Alabama?
Alabama hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Obesity, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Alabama serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Alabama?
To join a clinical trial in Alabama, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Alabama maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Alabama
NCT07503210 Phase 3
Recruiting
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Help...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT06565637 Phase 1
Recruiting
Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minor...
Condition
Eating Disorders
Enrollment
30 pts
Location
United States
Sponsor
Auburn University
NCT03127267 Phase 3
Recruiting
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Condition
Amyotrophic Lateral Sclerosis
Enrollment
495 pts
Location
United States, Belgium, Denmark
Sponsor
AB Science
NCT05372354 Phase 1, Phase 2
Recruiting
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-98634...
Condition
Multiple Myeloma
Enrollment
260 pts
Location
United States, Canada, Norway
Sponsor
Bristol-Myers Squibb
NCT07104656 N/A
Recruiting
Bony Overlap Following Use of the Inferior Border Saw for the 'Low and Short' Sa...
Condition
Mandibular Surgery
Enrollment
40 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT07215273 Phase 2
Recruiting
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifung...
Condition
Invasive Mould Infection
Enrollment
60 pts
Location
United States, Belgium, Canada
Sponsor
Elion Therapeutics, Inc.
NCT04875429 N/A
Recruiting
Zenith® Fenestrated+ Clinical Study
Condition
Aortic Aneurysm, Abdominal
Enrollment
105 pts
Location
United States, United Kingdom
Sponsor
Cook Research Incorporated
NCT06133972 Phase 3
Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participant...
Condition
Systemic Lupus Erythematosus
Enrollment
550 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT03503331 Phase 2
Recruiting
UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy
Condition
Alzheimer Disease
Enrollment
160 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT07089875 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Condition
Gout
Enrollment
500 pts
Location
United States, Poland, Spain
Sponsor
Crystalys Therapeutics
NCT05442567 Phase 3
Recruiting
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disea...
Condition
Ulcerative Colitis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Takeda
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT06736028 N/A
Recruiting
Ketogenic Diets for Weight Loss Maintenance: Impact on Energy Expenditure and Ap...
Condition
Obesity
Enrollment
20 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05617898 N/A
Recruiting
Determining the Role of Social Reward Learning in Social Anhedonia
Condition
Psychosis
Enrollment
152 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT04671667 Phase 2
Recruiting
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itse...
Condition
Recurrent Head and Neck Squamous Cell Carcinoma
Enrollment
188 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07339111 Phase 3
Recruiting
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cart...
Condition
Knee Cartilage Defects
Enrollment
300 pts
Location
United States
Sponsor
Medipost, Inc.
NCT07502495 Phase 2
Recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Ach...
Condition
Type 2 Diabetes
Enrollment
60 pts
Location
United States
Sponsor
Biomea Fusion Inc.
NCT07309445 N/A
Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With N...
Condition
Non-Muscle Invasive Bladder Neoplasms
Enrollment
150 pts
Location
United States
Sponsor
Janssen Research & Development
NCT05763251 N/A
Recruiting
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Condition
Invasive Candidiasis
Enrollment
420 pts
Location
United States, Australia
Sponsor
Arkansas Children's Hospital R
NCT05096273 N/A
Recruiting
Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectation...
Condition
Convulsion, Non-Epileptic
Enrollment
68 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT03403686 N/A
Recruiting
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR...
Condition
Diabetic Retinopathy
Enrollment
104 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06588556 N/A
Recruiting
Improving Needs Among Older Adults
Condition
Critical Illness
Enrollment
350 pts
Location
United States
Sponsor
Duke University
NCT06907979 N/A
Recruiting
Cannabis and Processing Emotions Study
Condition
Cannabis Use Disorder, Severe
Enrollment
24 pts
Location
United States
Sponsor
Auburn University
NCT06636786 Phase 2
Recruiting
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Subli...
Condition
Acute Stress Reaction
Enrollment
180 pts
Location
United States
Sponsor
University of North Carolina,
NCT04588922 Phase 1, Phase 2
Recruiting
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Pa...
Condition
Hematologic Malignancies
Enrollment
160 pts
Location
United States, China
Sponsor
Sellas Life Sciences Group
Page 1 of 8 — 191 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology